Nalbuphin OrPha, Injektionslösung

7680569890026 CH-56989 Injektionslösung
Nalbuphin OrPha, Injektionslösung
Nalbuphin OrPha, Injektionslösung
Nalbuphin OrPha, Injektionslösung
1 / 3
google

Article details

Package size
10 x 2
Selling units
10
Measure
ml
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
13/11/2024
Summary of Product Characteristics
Français
13/11/2024
Summary of Product Characteristics
Italien
13/11/2024

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.64 MG Substance HBESI

Authorization holder

OrPha Swiss GmbH

8700 Küsnacht ZH

Authorization information

Swissmedic authorization number
56989
Drug name
Nalbuphin OrPha, Injektionslösung
Galenic form
LSINJ
ATC Code
N02AF02
Authorization status
Z
Dispensing category
A
First authorization
15/10/2004
Authorization expiration date
31/12/9999
IT Number
01.01.3.
Domain
Human medicine
Field of application
Mittelschwere bis schwere Schmerzen

Package details

Description (FR)
NALBUPHIN OrPha sol inj 20 mg/2ml 10 amp 2 ml
Description (DE)
NALBUPHIN OrPha Inj Lös 20 mg/2ml 10 Amp 2 ml
Market launch
15/10/2004
Narcotic (BTM)
No